FDAnews
www.fdanews.com/articles/158907-sequenom-ponders-getting-rid-of-genetic-analysis-biz

Sequenom Ponders Getting Rid of Genetic Analysis Biz

September 25, 2013
Sequenom announced that its board of directors has authorized a review of potential strategic alternatives for its genetic analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the genetic analysis business segment.
DeviceSpace